Evaluation of high-sensitivity C-reactive protein in acute asthma

Tanaffos

Volumn 11, Issue 1, 2012, Pages 32-37

  Razi, Ebrahim ^a   Ehteram, Hassan ^a   Akbari, Hossein ^a   Chavoshi, Vajihe ^a   Razi, Armin ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asthma; C reactive protein; Pulmonary function tests; Sensitivity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 84858791724     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tall AR. C-reactive protein reassessed. N Engl J Med 2004; 350 (14): 1450-2.
2. Szalai AJ. C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin Dev Immunol 2004; 11 (3-4): 221-6.
3. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006; 27 (5): 908-12.
4. Fujita M, Ueki S, Ito W, Chiba T, Takeda M, Saito N, et al. C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 2007; 99 (1): 48-53.
5. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002; 89 (4): 381-5.
6. Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003; 40 (7): 733-9.
7. Sävykoski T, Harju T, Paldanius M, Kuitunen H, Bloigu A, Wahlström E, et al. Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration 2004; 71 (2): 120-5.
8. Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jögi R, et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60 (6): 451-4.
9. Cirillo DJ, Agrawal Y, Cassano PA. Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002; 155 (9): 842-8.
10. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350 (14): 1387-97.
11. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114 (9): 758-62.
12. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59 (7): 574-80.
13. Kony S, Zureik M, Driss F, Neukirch C, Leynaert B, Neukirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004; 59 (10): 892-6.
14. Williams SG, Schmidt DK, Redd SC, Storms W; National Asthma Education and Prevention Program. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep 2003; 52 (RR-6): 1-8.
15. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152 (3): 1107-36.
16. Büyüköztürk S, Gelincik AA, Genç S, Koçak H, Oneriyidogan Y, Erden S, et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med 2004; 204 (3): 209-13.
17. Enright PL, Ward BJ, Tracy RP, Lasser EC. Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. J Asthma 1996; 33 (1): 45-53.
18. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol 1996; 157 (1): 473-9.
19. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15 (2): 74-80.
20. Müller H, Fehr J. Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors. J Immunol 1986; 136 (6): 2202-7.
21. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282 (22): 2131-5.
22. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19 (4): 972-8.
23. Nakamura H, Yamashita T. Predictive value of cardiovascular events by high sensitivity CRP. Nihon Rinsho 2002; 60 (5): 916-21.
24. Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 2006; 100 (12): 2112-20.
25. Qian FH, Zhang Q, Zhou LF, Liu H, Huang M, Zhang XL, et al. High-sensitivity C-reactive protein: a predicative marker in severe asthma. Respirology 2008; 13 (5): 664-9.
26. Ramirez D, Patel P, Casillas A, Cotelingam J, Boggs P, Bahna SL. Assessment of high-sensitivity C-reactive protein as a marker of airway inflammation in asthma. Ann Allergy Asthma Immunol 2010; 104 (6): 485-9.
27. Wu SH, Yin PL, Zhang YM, Tao HX. Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree. Pediatr Pulmonol 2010; 45 (4): 333-40.